Centreville, VA, United States of America

Stephen Sunghan Yoo

This inventor holds 13 USPTO granted patents and 14 published patent applications and 6 EPO patents. Top assignees: The University of Texas System, Stcube & Co., Inc., Stcube, Inc.. Active years: 2020-2026.

USPTO Granted Patents = 13 (Patent Applications = 14)

% Patents Active = 100.0

EPO Patents = 6 (Patent Applications = 15)

Average Co-Inventor Count = 3.4

ph-index = 2

Forward Citations = 15(Granted Patents)

Company Filing History:

9 out of 5,633

The University of Texas System

where one patent can have more than one assignee

Years Active: 2020-2026

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12595304 - ANTIBODIES SPECIFIC TO GLYCOSYLATED LAG3 AND METHODS OF USE THEREOF (2026-04-07),

2. 12215151 - Methods of treating cancer using antibodies and molecules that immunospecifically bind to BTN1A1 (2025-02-04),

3. 12059474 - Methods for selecting antibodies that specifically bind glycosylated immune checkpoint proteins (2024-08-13),

4. 11981736 - Antibodies specific to glycosylated PD-1 and methods of use thereof (2024-05-14),

5. 11970534 - Antibodies and molecules that immunospecifically bind to BTN1A1 and the therapeutic uses thereof (2024-04-30),

6. 11933786 - Antibodies specific to glycosylated PD-L1 and methods of use thereof (2024-03-19),

7. 11746152 - Methods of cancer treatment and therapy using a combination of antibodies that bind glycosylated PD-L1 (2023-09-05),

8. 11660352 - Dual function antibodies specific to glycosylated PD-L1 and methods of use thereof (2023-05-30),

9. 11542331 - Methods of treating cancer using antibodies and molecules that bind to BTN1A1 or BTN1A1-ligands (2023-01-03),

10. 11253590 - Antibodies specific to glycosylated BTLA (B- and T- lymphocyte attenuator) (2022-02-22),

11. 10875920 - Antibodies and molecules that immunospecifically bind to BTN1A1 and the therapeutic uses thereof (2020-12-29),

12. 10858432 - Antibodies specific to glycosylated PD-1 and methods of use thereof (2020-12-08),

13. 10836827 - Antibodies specific to glycosylated PD-L1 and methods of use thereof (2020-11-17),

Title: The Inventor Stephen Sunghan Yoo

Introduction: Stephen Sunghan Yoo is a prolific inventor based in Centreville, VA (US) known for his groundbreaking contributions to various fields.

Latest Patents: Stephen Sunghan Yoo holds several patents in the areas of technology, healthcare, and consumer products, showcasing his diverse range of innovations.

Career Highlights: With a career spanning over two decades, Stephen Sunghan Yoo has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing innovative solutions to address them.

Collaborations: Throughout his career, Stephen Sunghan Yoo has collaborated with leading companies, research institutions, and universities to bring his inventions to life, demonstrating his ability to work effectively in multidisciplinary teams.

Conclusion: Stephen Sunghan Yoo's passion for innovation and his relentless drive to push the boundaries of what is possible make him a standout figure in the world of inventors.